ScholarLens Back to search
1996•PubMedRequires access

OVULATION INHIBITION BY LYNDIOL: A CLINICAL TRIAL.

K Turpeinen

Open publisher page 2 citations

Abstract

120 women 19-35 years old received Lyndiol (5 mg lynestrenol and .15 mg ethinyl estradiol) daily for 3 out of every 4 weeks for a total of 876 woman-months of use. The withdrawal rate was 23% with 10% withdrawing because of side effects including nausea amenorrhea dysmenorrhea weight gain headache pain and vaginal discharge. Breakthrough bleeding occurred only once during the experiment. 1 pregnancy was reported in a case in which the woman did not take the pills properly. It was concluded that Lyndiol is an effective contraceptive with minimal side effects and very good patient acceptance.

About this research paper

What this paper is about

120 women 19-35 years old received Lyndiol (5 mg lynestrenol and .15 mg ethinyl estradiol) daily for 3 out of every 4 weeks for a total of 876 woman-months of use. The withdrawal rate was 23% with 10% withdrawing because of side effects including nausea amenorrhea dysmenorrhea weight gain headache pain and vaginal discharge. Breakthrough bleeding occurred only once during the experiment. 1 pregnancy was reported in a case in which the woman did not take the pills properly. It was concluded that Lyndiol is an effective contraceptive with minimal side effects and very good patient acceptance.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

120 women 19-35 years old received Lyndiol (5 mg lynestrenol and .15 mg ethinyl estradiol) daily for 3 out of every 4 weeks for a total of 876 woman-months of use. The withdrawal rate was 23% with 10% withdrawing because of side effects including nausea amenorrhea dysmenorrhea weight gain headache pain and vaginal discharge. Breakthrough bleeding occurred only once during the experiment. 1 pregnancy was reported in a case in which the woman did not take the pills properly. It was concluded that Lyndiol is an effective contraceptive with minimal side effects and very good patient acceptance.

Key concepts: Lynestrenol, Mestranol, Medicine, Breakthrough bleeding, Nausea, Amenorrhea, Ovulation, Pill

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
OVULATION INHIBITION BY LYNDIOL: A CLINICAL TRIAL. — Research Paper | ScholarLens